Target intelligence / Profile preview

Transcriptional enhanced associate domain protein 4 mRNA (TEAD4 mRNA)

Target
TEAD4 mRNA
Molecular classification
Messenger RNA, Transcription factor (encoded protein)
01

Overview

Transcriptional enhanced associate domain protein 4 (TEAD4) mRNA is the transcript encoding a key transcription factor within the Hippo signaling pathway. The TEAD4 protein acts as a primary nuclear partner for the transcriptional co-activators YAP and TAZ, facilitating the expression of genes that promote cell survival, proliferation, and stemness (PMID: 31434659). In various malignancies, TEAD4 is frequently overexpressed or hyperactivated, contributing to tumor progression, metastasis, and resistance to therapy (PMID: 30217974). Targeting TEAD4 at the mRNA level using antisense oligonucleotides or RNA interference offers a strategy to deplete the protein product, which is traditionally considered difficult to target with small molecules due to its lack of conventional binding pockets. This approach aims to disrupt the YAP/TAZ-TEAD transcriptional output, thereby inhibiting oncogenic signaling in Hippo-deficient or YAP/TAZ-driven cancers. By reducing the levels of TEAD4 mRNA, researchers hope to suppress the epithelial-mesenchymal transition and increase the sensitivity of cancer cells to existing treatments (NCBI Gene ID: 7004).

Other names
TEA domain family member 4 mRNATranscription factor 13 mRNATCF13 mRNATEF-3 mRNARTEF-1 mRNAhRTEF-1 mRNA
02

Mechanism of action

RNA interference (RNAi) or RNase H-mediated degradation of the mRNA transcript to prevent translation into the TEAD4 protein, thereby inhibiting the formation of the YAP/TAZ-TEAD transcriptional complex.

03

Biological functions

Transcription regulationHippo signaling pathwayCell proliferationApoptosis regulationEmbryonic developmentEpithelial-mesenchymal transition (EMT)
04

Disease associations

CancerGastric cancerColorectal cancerBreast cancerLung cancerProstate cancerHepatocellular carcinoma
05

Safety considerations

Off-target effects of nucleic acid therapeuticsSystemic delivery challenges to solid tumorsPotential toxicity in tissues requiring Hippo signaling for homeostasis (e.g., liver, skin)Innate immune activation by synthetic oligonucleotides
06

Interacting drugs

Antisense oligonucleotides (ASOs)

1 more in the full profile.

07

Biomarkers

TEAD4 mRNA expression levelsYAP1 expressionTAZ (WWTR1) expressionHippo pathway mutation status (e.g., NF2, LATS1/2)

Beyond the preview

Go deeper on Transcriptional enhanced associate domain protein 4 mRNA (TEAD4 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcriptional enhanced associate domain protein 4 mRNA (TEAD4 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call